254 related articles for article (PubMed ID: 27195454)
1. Late Toxicities of Intensity-Modulated Radiation Therapy for Head and Neck Rhabdomyosarcoma.
Lockney NA; Friedman DN; Wexler LH; Sklar CA; Casey DL; Wolden SL
Pediatr Blood Cancer; 2016 Sep; 63(9):1608-14. PubMed ID: 27195454
[TBL] [Abstract][Full Text] [Related]
2. Long-term effects in children treated with radiotherapy for head and neck rhabdomyosarcoma.
Paulino AC; Simon JH; Zhen W; Wen BC
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1489-95. PubMed ID: 11121653
[TBL] [Abstract][Full Text] [Related]
3. Intensity Modulated Radiotherapy (IMRT) and Fractionated Stereotactic Radiotherapy (FSRT) for children with head-and-neck-rhabdomyosarcoma.
Combs SE; Behnisch W; Kulozik AE; Huber PE; Debus J; Schulz-Ertner D
BMC Cancer; 2007 Sep; 7():177. PubMed ID: 17854490
[TBL] [Abstract][Full Text] [Related]
4. Intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma.
Wolden SL; Wexler LH; Kraus DH; Laquaglia MP; Lis E; Meyers PA
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1432-8. PubMed ID: 15817347
[TBL] [Abstract][Full Text] [Related]
5. Local control after intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma.
Curtis AE; Okcu MF; Chintagumpala M; Teh BS; Paulino AC
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):173-7. PubMed ID: 18501529
[TBL] [Abstract][Full Text] [Related]
6. Late complications of therapy in 213 children with localized, nonorbital soft-tissue sarcoma of the head and neck: A descriptive report from the Intergroup Rhabdomyosarcoma Studies (IRS)-II and - III. IRS Group of the Children's Cancer Group and the Pediatric Oncology Group.
Raney RB; Asmar L; Vassilopoulou-Sellin R; Klein MJ; Donaldson SS; Green J; Heyn R; Wharam M; Glicksman AS; Gehan EA; Anderson J; Maurer HM
Med Pediatr Oncol; 1999 Oct; 33(4):362-71. PubMed ID: 10491544
[TBL] [Abstract][Full Text] [Related]
7. Intensity-modulated radiotherapy with use of cone-down boost for pediatric head-and-neck rhabdomyosarcoma.
McDonald MW; Esiashvili N; George BA; Katzenstein HM; Olson TA; Rapkin LB; Marcus RB
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):884-91. PubMed ID: 18455321
[TBL] [Abstract][Full Text] [Related]
8. Favorable outcomes after whole abdominopelvic radiation therapy for pediatric and young adult sarcoma.
Casey DL; Wexler LH; LaQuaglia MP; Meyers PA; Wolden SL
Pediatr Blood Cancer; 2014 Sep; 61(9):1565-9. PubMed ID: 24798662
[TBL] [Abstract][Full Text] [Related]
9. Correlation of Acute and Late Brainstem Toxicities With Dose-Volume Data for Pediatric Patients With Posterior Fossa Malignancies.
Nanda RH; Ganju RG; Schreibmann E; Chen Z; Zhang C; Jegadeesh N; Cassidy R; Deng C; Eaton BR; Esiashvili N
Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):360-366. PubMed ID: 28463155
[TBL] [Abstract][Full Text] [Related]
10. Proton therapy for pediatric head and neck malignancies.
Vogel J; Both S; Kirk M; Chao HH; Bagatell R; Li Y; Womer R; Balamuth N; Reilly A; Kurtz G; Lustig R; Tochner Z; Hill-Kayser C
Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 29058370
[TBL] [Abstract][Full Text] [Related]
11. A dosimetric comparison of proton and intensity-modulated photon radiotherapy for pediatric parameningeal rhabdomyosarcomas.
Kozak KR; Adams J; Krejcarek SJ; Tarbell NJ; Yock TI
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):179-86. PubMed ID: 19019562
[TBL] [Abstract][Full Text] [Related]
12. Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy.
Klem ML; Mechalakos JG; Wolden SL; Zelefsky MJ; Singh B; Kraus D; Shaha A; Shah J; Pfister DG; Lee NY
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1100-7. PubMed ID: 17980501
[TBL] [Abstract][Full Text] [Related]
13. Late effects of therapy in 94 patients with localized rhabdomyosarcoma of the orbit: Report from the Intergroup Rhabdomyosarcoma Study (IRS)-III, 1984-1991.
Raney RB; Anderson JR; Kollath J; Vassilopoulou-Sellin R; Klein MJ; Heyn R; Glicksman AS; Wharam M; Crist WM; Maurer HM
Med Pediatr Oncol; 2000 Jun; 34(6):413-20. PubMed ID: 10842248
[TBL] [Abstract][Full Text] [Related]
14. Endocrine disorders among long-term survivors of childhood head and neck rhabdomyosarcoma.
Clement SC; Schoot RA; Slater O; Chisholm JC; Abela C; Balm AJM; van den Brekel MW; Breunis WB; Chang YC; Davila Fajardo R; Dunaway D; Gajdosova E; Gaze MN; Gupta S; Hartley B; Kremer LCM; van Lennep M; Levitt GA; Mandeville HC; Pieters BR; Saeed P; Smeele LE; Strackee SD; Ronckers CM; Caron HN; van Santen HM; Merks JHM
Eur J Cancer; 2016 Feb; 54():1-10. PubMed ID: 26707591
[TBL] [Abstract][Full Text] [Related]
15. Proton radiotherapy for pediatric bladder/prostate rhabdomyosarcoma: clinical outcomes and dosimetry compared to intensity-modulated radiation therapy.
Cotter SE; Herrup DA; Friedmann A; Macdonald SM; Pieretti RV; Robinson G; Adams J; Tarbell NJ; Yock TI
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1367-73. PubMed ID: 20934266
[TBL] [Abstract][Full Text] [Related]
16. Excellent local control and survival after postoperative or definitive radiation therapy for sarcomas of the head and neck.
Andrä C; Rauch J; Li M; Ganswindt U; Belka C; Saleh-Ebrahimi L; Ballhausen H; Nachbichler SB; Roeder F
Radiat Oncol; 2015 Jul; 10():140. PubMed ID: 26156022
[TBL] [Abstract][Full Text] [Related]
17. Parameningeal rhabdomyosarcoma: outcomes and opportunities.
Yang JC; Wexler LH; Meyers PA; Wolden SL
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e61-6. PubMed ID: 23021437
[TBL] [Abstract][Full Text] [Related]
18. A dosimetric comparison of proton and intensity modulated radiation therapy in pediatric rhabdomyosarcoma patients enrolled on a prospective phase II proton study.
Ladra MM; Edgington SK; Mahajan A; Grosshans D; Szymonifka J; Khan F; Moteabbed M; Friedmann AM; MacDonald SM; Tarbell NJ; Yock TI
Radiother Oncol; 2014 Oct; 113(1):77-83. PubMed ID: 25443861
[TBL] [Abstract][Full Text] [Related]
19. Intensity-modulated radiation therapy with dose-painting for pediatric sarcomas with pulmonary metastases.
Yang JC; Wexler LH; Meyers PA; Happersett L; La Quaglia MP; Wolden SL
Pediatr Blood Cancer; 2013 Oct; 60(10):1616-20. PubMed ID: 23765910
[TBL] [Abstract][Full Text] [Related]
20. Long-term effect of chemotherapy-intensity-modulated radiation therapy (chemo-IMRT) on dentofacial development in head and neck rhabdomyosarcoma patients.
Owosho AA; Brady P; Wolden SL; Wexler LH; Antonescu CR; Huryn JM; Estilo CL
Pediatr Hematol Oncol; 2016 Sep; 33(6):383-392. PubMed ID: 27689858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
